Rhenman & Partners Asset Management AB as of June 30, 2019
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 88 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) | 3.7 | $34M | 185k | 183.38 | |
Humana (HUM) | 3.1 | $28M | 105k | 265.30 | |
Jazz Pharmaceuticals (JAZZ) | 2.9 | $27M | 187k | 142.56 | |
Alexion Pharmaceuticals | 2.9 | $27M | 203k | 130.98 | |
Horizon Ban (HBNC) | 2.9 | $26M | 1.1M | 24.06 | |
Nektar Therapeutics (NKTR) | 2.8 | $26M | 725k | 35.58 | |
UnitedHealth (UNH) | 2.8 | $26M | 105k | 244.01 | |
Anthem (ELV) | 2.8 | $25M | 90k | 282.21 | |
Abiomed | 2.7 | $24M | 93k | 260.50 | |
BioMarin Pharmaceutical (BMRN) | 2.6 | $24M | 281k | 85.65 | |
Novocure Ltd ord (NVCR) | 2.5 | $23M | 366k | 63.23 | |
Abbott Laboratories (ABT) | 2.4 | $22M | 260k | 84.10 | |
Becton, Dickinson and (BDX) | 2.2 | $20M | 80k | 252.01 | |
Esperion Therapeutics (ESPR) | 2.1 | $19M | 412k | 46.52 | |
CVS Caremark Corporation (CVS) | 2.1 | $19M | 344k | 54.49 | |
Mirati Therapeutics | 2.1 | $19M | 182k | 103.00 | |
Hca Holdings (HCA) | 2.0 | $18M | 136k | 135.17 | |
Iovance Biotherapeutics (IOVA) | 2.0 | $18M | 751k | 24.52 | |
Glaukos (GKOS) | 2.0 | $18M | 236k | 75.40 | |
Eli Lilly & Co. (LLY) | 1.9 | $18M | 160k | 110.79 | |
Boston Scientific Corporation (BSX) | 1.8 | $17M | 388k | 42.98 | |
Medtronic (MDT) | 1.8 | $16M | 163k | 97.39 | |
Fibrogen (FGEN) | 1.7 | $16M | 347k | 45.18 | |
Centene Corporation (CNC) | 1.7 | $16M | 295k | 52.44 | |
Bristol Myers Squibb (BMY) | 1.7 | $15M | 338k | 45.35 | |
Neurocrine Biosciences (NBIX) | 1.7 | $15M | 180k | 84.43 | |
Cigna Corp (CI) | 1.7 | $15M | 96k | 157.55 | |
Macrogenics (MGNX) | 1.6 | $15M | 857k | 16.97 | |
Regeneron Pharmaceuticals (REGN) | 1.6 | $14M | 45k | 312.99 | |
Xencor (XNCR) | 1.4 | $13M | 320k | 40.93 | |
Intra Cellular Therapies (ITCI) | 1.4 | $12M | 950k | 12.98 | |
AmerisourceBergen (COR) | 1.3 | $12M | 142k | 85.26 | |
Immunomedics | 1.3 | $12M | 851k | 13.87 | |
Myokardia | 1.2 | $11M | 225k | 50.14 | |
Livanova Plc Ord (LIVN) | 1.2 | $11M | 150k | 71.96 | |
EXACT Sciences Corporation (EXAS) | 1.2 | $11M | 90k | 118.04 | |
Agios Pharmaceuticals (AGIO) | 1.1 | $10M | 200k | 49.88 | |
Arena Pharmaceuticals | 1.1 | $10M | 170k | 58.63 | |
Exelixis (EXEL) | 1.1 | $9.8M | 460k | 21.37 | |
Seattle Genetics | 1.0 | $9.4M | 135k | 69.21 | |
Bluebird Bio (BLUE) | 1.0 | $8.9M | 70k | 127.20 | |
Thermo Fisher Scientific (TMO) | 1.0 | $8.8M | 30k | 293.69 | |
Omnicell (OMCL) | 0.9 | $8.6M | 100k | 86.03 | |
Coherus Biosciences (CHRS) | 0.9 | $8.6M | 390k | 22.10 | |
Incyte Corporation (INCY) | 0.9 | $8.5M | 100k | 84.96 | |
Sangamo Biosciences (SGMO) | 0.9 | $8.6M | 794k | 10.77 | |
G1 Therapeutics | 0.9 | $8.4M | 274k | 30.66 | |
Aerie Pharmaceuticals | 0.8 | $7.7M | 260k | 29.55 | |
D Stemline Therapeutics | 0.8 | $7.6M | 494k | 15.32 | |
Diplomat Pharmacy | 0.8 | $7.3M | 1.2M | 6.09 | |
Medicines Company | 0.8 | $7.3M | 200k | 36.47 | |
Ra Pharmaceuticals | 0.8 | $6.9M | 229k | 30.07 | |
Amarin Corporation (AMRN) | 0.8 | $6.8M | 351k | 19.39 | |
Epizyme | 0.7 | $6.2M | 494k | 12.55 | |
Rigel Pharmaceuticals | 0.7 | $5.9M | 2.3M | 2.61 | |
Alnylam Pharmaceuticals (ALNY) | 0.7 | $5.9M | 82k | 72.56 | |
Edwards Lifesciences (EW) | 0.6 | $5.8M | 32k | 184.74 | |
Viewray (VRAYQ) | 0.6 | $5.9M | 664k | 8.81 | |
Dynavax Technologies (DVAX) | 0.5 | $4.9M | 1.2M | 3.99 | |
Dermira | 0.5 | $4.8M | 500k | 9.56 | |
Sage Therapeutics (SAGE) | 0.4 | $4.0M | 22k | 183.10 | |
Madrigal Pharmaceuticals (MDGL) | 0.4 | $3.9M | 37k | 104.82 | |
Nanostring Technologies (NSTGQ) | 0.4 | $3.6M | 120k | 30.35 | |
HMS Holdings | 0.4 | $3.2M | 100k | 32.39 | |
Abeona Therapeutics | 0.3 | $3.1M | 649k | 4.78 | |
Aimmune Therapeutics | 0.3 | $3.1M | 149k | 20.82 | |
Intercept Pharmaceuticals In | 0.3 | $3.0M | 38k | 79.57 | |
Acceleron Pharma | 0.3 | $2.9M | 70k | 41.09 | |
Alkermes (ALKS) | 0.3 | $2.7M | 120k | 22.54 | |
Revance Therapeutics (RVNC) | 0.3 | $2.5M | 193k | 12.97 | |
Viking Therapeutics (VKTX) | 0.3 | $2.4M | 292k | 8.30 | |
Qiagen Nv | 0.3 | $2.4M | 60k | 40.63 | |
Pieris Pharmaceuticals | 0.2 | $1.4M | 300k | 4.70 | |
Adverum Biotechnologies | 0.2 | $1.4M | 120k | 11.89 | |
Spark Therapeutics | 0.1 | $1.0M | 10k | 102.40 | |
Achillion Pharmaceuticals | 0.1 | $745k | 278k | 2.68 | |
Chevron Corporation (CVX) | 0.0 | $370k | 3.0k | 124.41 | |
JPMorgan Chase & Co. (JPM) | 0.0 | $276k | 2.5k | 111.65 | |
Exxon Mobil Corporation (XOM) | 0.0 | $295k | 3.9k | 76.54 | |
Walt Disney Company (DIS) | 0.0 | $291k | 2.1k | 139.70 | |
Wells Fargo & Company (WFC) | 0.0 | $249k | 5.3k | 47.23 | |
International Business Machines (IBM) | 0.0 | $305k | 2.2k | 137.70 | |
Qualcomm (QCOM) | 0.0 | $258k | 3.4k | 76.08 | |
Ford Motor Company (F) | 0.0 | $298k | 29k | 10.22 | |
Anheuser-Busch InBev NV (BUD) | 0.0 | $302k | 3.4k | 88.59 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $275k | 377k | 0.73 | |
Janus Henderson Group Plc Ord (JHG) | 0.0 | $228k | 11k | 21.42 | |
Microsoft Corporation (MSFT) | 0.0 | $205k | 1.5k | 133.81 |